Roche’s tumour-agnostic therapy Rozlytrek approved in EU

4th August 2020 Uncategorised 0

Therapy has been approved to treat advanced NTRK fusion-positive solid tumours

More: Roche’s tumour-agnostic therapy Rozlytrek approved in EU
Source: News